Live feed09:00:00·39mPRReleasevia QuantisnowOncolytics Biotech® Aligns with FDA on Registrational Path for Second-Line RAS-Mutant MSS Colorectal CancerByQuantisnow·Wall Street's wire, on your screen.ONCY· Oncolytics Biotech Inc.Health Care
